ENODIA THERAPEUTICS: WILL CONDUCT DISCOVERY ACTIVITIES TO SCREEN, OPTIMIZE, DEVELOP SEC61 INHIBITOR CANDIDATES AGAINST MULTIPLE COLLABORATION TARGETS

Reuters · 1d ago

Please log in to view news